Creative Biolabs-Immuno-oncology

Anti-CD22 (clone I1DD322-26) SynExpress SP-Cy3-GR-E CD8+ T Cells (CAT#: ITS-1124-CR51)

DatasheetDatasheet
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1DD322-26). We employs the Retrovirus (SP6-Cy3-GR-EcoRI) vector components and the SynExpress system of the exons Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1DD322-26
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
SP6
Effector Gene
GR
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.95
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.